LBWM
AMGN icon

Left Brain Wealth Management’s Amgen AMGN Stock Holding History

Left Brain Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$629K Sell
1,787
-15
-0.8% -$5.35K 0.25% 50
2025
Q4 		$590K Sell
1,802
-30
-2% -$9.52K 0.2% 54
2025
Q3 		$517K Sell
1,832
-129
-7% -$37.4K 0.16% 71
2025
Q2 		$548K Sell
1,961
-176
-8% -$49.9K 0.19% 61
2025
Q1 		$666K Sell
2,137
-86
-4% -$25.4K 0.29% 53
2024
Q4 		$579K Buy
2,223
+10
+0.5% +$2.97K 0.22% 63
2024
Q3 		$713K Buy
2,213
+118
+6% +$38.6K 0.33% 54
2024
Q2 		$655K Buy
2,095
+15
+0.7% +$4.41K 0.31% 52
2024
Q1 		$591K Buy
2,080
+67
+3% +$19.6K 0.29% 55
2023
Q4 		$580K Buy
2,013
+39
+2% +$10.6K 0.34% 58
2023
Q3 		$531K Buy
1,974
+164
+9% +$40.9K 0.33% 60
2023
Q2 		$402K Sell
1,810
-100
-5% -$23.2K 0.25% 67
2023
Q1 		$458K Sell
1,910
-13,093
-87% -$3.21M 0.31% 60
2022
Q4 		$3.94M Buy
+15,003
New +$4.02M 2.95% 12

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Left Brain Wealth Management's AMGN Position: Q1 2026 in Review

Left Brain Wealth Management reduced its Amgen (AMGN) stake by 0.83% in Q1 2026, selling an estimated $5.35K and leaving 1,787 shares worth $629K. The position accounts for 0.25% of the portfolio, ranked #50.

Left Brain Wealth Management first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.94M in Q4 2022. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Left Brain Wealth Management held 1,787 shares of Amgen worth $629K as of Q1 2026.
  • Left Brain Wealth Management sold 15 Amgen shares in Q1 2026, an estimated $5.35K.
  • Amgen made up 0.25% of Left Brain Wealth Management's portfolio in Q1 2026, its #50 holding.
  • Left Brain Wealth Management first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • Left Brain Wealth Management's Amgen position peaked at $3.94M in Q4 2022.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Left Brain Wealth Management's 13F filing for Q1 2026, filed 30 Apr 2026.